Quanterix (QTRX) Change in Account Payables (2017 - 2026)
Quanterix's (QTRX) quarterly Change in Account Payables came in at -$4.8 million in Q1 2026, down 1314.54% YoY from $399000.0 in Q1 2025, and down 261.05% on a QoQ basis from $3.0 million in Q4 2025.
Quanterix (QTRX) Change in Account Payables (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Change in Account Payables data on file, last reported at -$4.8 million in Q1 2026.
- Quarterly Change in Account Payables fell 1314.54% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.8 million (down 364.94% YoY) and the FY2025 annual result came in at -$528000.0, down 173.03% from the prior year.
- Change in Account Payables fell to -$4.8 million in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.1 million in Q2 2024 to a low of -$6.3 million in Q3 2025.
- A 5-year average of -$514647.1 and a median of $241000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables jumped 2128.89% — and 2026, when it plunged 1314.54%.
- Tracing QTRX's Change in Account Payables over 5 years: stood at $1.7 million in 2022, then tumbled by 86.01% to $241000.0 in 2023, then sank by 43.98% to $135000.0 in 2024, then jumped by 2128.89% to $3.0 million in 2025, then sank by 261.05% to -$4.8 million in 2026.
- The last three Change in Account Payables figures came in at -$4.8 million (Q1 2026), $3.0 million (Q4 2025), and -$6.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn | -1.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.92 Mn |
| Jun 30, 2026 | -1.92 Mn |
| Mar 31, 2026 | -4.85 Mn |
| Mar 31, 2026 | -4.85 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Sep 30, 2025 | -6.33 Mn |
| Sep 30, 2025 | -6.33 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 399,000.00 |
| Mar 31, 2025 | 399,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | -1.47 Mn |
| Sep 30, 2024 | -1.47 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Mar 31, 2024 | -1.06 Mn |